| Characteristic | Total | Embolism | No embolism | | () | () | () |
| Female/male | 12/15 | 9/6 | 6/6 | 0.863 | Age, y (mean ± SD) | | | | 0.708 | Hypertension, (%) | 9 (33.3%) | 6 (40%) | 3 (25%%) | 0.683 | Hyperlipidemia, (%) | 5 (18.5%) | 4 (26.5%) | 1 (8.3%) | 0.342 | Vascular malformation, (%) | 2 (7.4%) | 2 (13.3%) | 0 | 0.487 | Diabetes at baseline, (%) | 2 (7.4%) | 0 | 2 (16.7%) | 0.188 | Coronary artery disease, (%) | 3 (11.1%) | 2 (13.3%) | 1 (8.3%) | 1 | Atrial fibrillation, (%) | 5 (18.5%) | 3 (20%) | 2 (16.7%) | 1 | Infection, (%) | 8 (29.6%) | 7 (46.7%) | 1 (8.3%) | 0.043 | Death, (%) | 4 (14.8%) | 3 (20%) | 1* (8.3%) | 0.605 | Complement 4, g/L (mean ± SD) | | | | 0.036 | Low-density lipoprotein, mmol/L (mean ± SD) | | | | 0.017 | Creatinine kinase-MB, U/L (mean ± SD) | | | | 0.05 | Lactate dehydrogenase, U/L (mean ± SD) | | | | 0.037 | Hydroxybutyrate dehydrogenase, U/L (mean ± SD) | | | | 0.078 | Platelet count, ×109/L (mean ± SD) | | | | 0.383 | Red blood cell count, ×109/L (mean ± SD) | | | | 0.054 | White blood cell count, ×109/L (mean ± SD) | | | | 0.049 | Echocardiography Features | | | | | Myxomas length cm (mean ± SD) | | | | 0.233 | Attached to atrial septum, (%) | 24 (88.9%) | 14 (93.3%) | 10 (83.3%) | 0.569 | High echo, (%) | 22 (81.5%) | 12 (80%) | 10 (83.3%) | 1 | Irregular shape, (%) | 23 (85.2%) | 15 (100%) | 8 (66.7%) | 0.028 | Peduncle, (%) | 21 (77.8%) | 11 (73.3%) | 10 (83.3%) | 0.662 | Prolapse into valve, (%) | 22 (81.5%) | 14 (93.3%) | 8 (66.7%) | 0.139 | Aortosclerosis, (%) | 17 (63.0%) | 10 (66.7%) | 7 (58.3%) | 0.371 | Aortic valve regurgitation, (%) | 10 (37.0%) | 5 (33.3%) | 5 (41.7%) | 0.706 | Mitral valve regurgitation, (%) | 12 (44.4%) | 7 (46.7%) | 5 (41.7%) | 1 | Tricuspid valve regurgitation, (%) | 15 (55.6%) | 7 (46.7%) | 8 (66.7%) | 0.441 | Lower left ventricular compliance, (%) | 10 (37.0%) | 7 (46.7%) | 3 (25%) | 0.424 | Heart enlargement, (%) | 13 (48.1%) | 6 (40%) | 7 (58.3%) | 0.449 |
|
|